Prostate-Specific Membrane Antigen (PSMA) is the hallmark enzyme-biomarker for prostate cancer as it is expressed in the epithelium of nearly all prostate cancers, and increased expression correlates with progression to castration resistance and metastatic disease (30–32). Here, FOLH1 is linked to prostate carcinoma.